XNAS · CGEN
-0.57% · -$0.0150 · Vol Not reported
Pre-market · updated 06:18:18 ET
Compugen Ltd

Compugen Ltd

$2.60
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
CGEN
Compugen Ltd
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CGEN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CGEN catalysts
About Compugen Ltd
Listed since
2000
Employees
75
Country
US

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.62
Last session
Day high
$2.62
Last session
Day low
$2.62
Last session
Previous close
$2.62
52W high
$3.10
-16.13% from high
52W low
$1.33
72% of range
Market cap
$247.7M
Beta
1.36
Shares out
94.7M
Avg volume
275.7K
VWAP
$2.62
Last session
Price history computed in-house
1W
+10.64%
1M
+14.04%
3M
-1.89%
1Y
+79.31%
YTD
+69.93%
SMA 50 $2.29 · above
SMA 200 $2.12 · above
52W position 72%

CGEN overview

Veridion Score
65
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CGEN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CGEN Form 4 filings
Public disclosures

Congress activity in CGEN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CGEN in the cached public ledger.

Federal contracts

CGEN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CGEN in this window.
Lobbying spend

CGEN lobbying filings, year to date.

Registered lobbying filings matched to Compugen Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CGEN in this window.
Loading news for CGEN
Analyst ratings
Sovereign unlock shows live analyst consensus for CGEN.
Options
Sovereign unlock shows live options positioning for CGEN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.